Happy 4th to the amazing people, places and ideals of the USA 🇺🇸

IMIDomics discovered the initial science, and now Formation Bio is taking it forward to clinical development. Today we announced our license of IMIDomics' first-in-class, Phase-1 ready anti-CD226 antibody targeting Ulcerative Colitis. Go behind the scenes with both teams here.

our most cutting edge companies are consistently Modal power users now, DIMENSION is also a proud Modal investor. thrilled to join Erik Bernhardsson & Akshat Bubna on their quest to reimagine infrastructure in the age of AI!!

New on the blog: how Formation Bio’s drug canvassing system uncovers “dark” or deprioritized assets, turning overlooked data into concrete signals for our BD team. Read the full piece here: formation.bio/blog/searching…

Today we're announcing a new addition to our pipeline: LNK01006, a next-generation CNS-penetrant TYK2 inhibitor licensed from Lynk Pharmaceuticals. Phase 1 is planned for the first half of 2026. In our latest video, hear from our team who brought the LNK01006 deal to life, including more

New on our blog: Cohen Karnell, software engineer at Formation Bio, shares how we transformed a decade’s worth of unstructured clinical trial data into a standardized data foundation for faster, smarter clinical development. Read here: formation.bio/blog/structuri…

The Flatiron 1903 Alfred Stieglitz

Happy to see Claude is aware of Autoprotocol for specifying wet lab experiments

Proud to announce that Formation Bio has acquired worldwide rights, excluding greater China, to FHND5032, a small-molecule miR-124 activator for autoimmune diseases. This marks our third acquisition in six months, and we plan to enter the clinic in 2026. Go behind the scenes of

If you can afford to pull up to sf for 12-30 weeks, you could change your entire life.

Curating

A new future, a new you.

Missed opportunity by Valar Atomics for “Make America Nuclear Again” we could have been mana-maxing

I have been enjoying the Marathon server slam and am so enjoying the visual style

Sekiguchi Genetics fan art for Marathon I made from genetically engineered E. coli, via the cloud lab Ginkgo Bioworks #marathon #fanart